Maiken Keson-Brookes

Insider Reports History

Location
Fayville, MA
Signature
/s/ Maiken Keson-Brookes
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Maiken Keson-Brookes:

Company Role Class Num Shares Value Price $ Report Date Ownership
Mural Oncology plc Chief Legal Officer Stock Option (right to buy) 0 $217,750 $3.35 05 Dec 2025 Direct
Mural Oncology plc Chief Legal Officer Ordinary Shares 0 $0 $2.07 05 Dec 2025 Direct
Rubius Therapeutics, Inc. CLO & Corp. Secretary Stock Option (Right to Buy) 143,750 31 Jan 2022 Direct
Rubius Therapeutics, Inc. CLO & Corp. Secretary Restricted Stock Units 34,500 31 Jan 2022 Direct
Rubius Therapeutics, Inc. CLO & Corp. Secretary Common Stock 5,343 01 Feb 2022 Direct

Insider Reports Filed by Maiken Keson-Brookes

Symbol Company Period Transactions Value $ Form Type Role Filing Time
MURA Mural Oncology plc 05 Dec 2025 4 $0 4 Chief Legal Officer 05 Dec 2025, 08:52
MURA Mural Oncology plc 22 Jul 2025 1 -$6,379 4 Chief Legal Officer and Secretary 23 Jul 2025, 17:00
MURA Mural Oncology plc 18 Jul 2025 1 -$5,352 4 Chief Legal Officer and Secretary 22 Jul 2025, 17:00
MURA Mural Oncology plc 03 Mar 2025 4 -$9,308 4 Chief Legal Officer and Secretary 05 Mar 2025, 16:49
MURA Mural Oncology plc 23 Dec 2024 1 -$8,355 4 Chief Legal Officer and Secretary 26 Dec 2024, 16:02
MURA Mural Oncology plc 18 Jul 2024 1 -$7,355 4 Chief Legal Officer and Secretary 18 Jul 2024, 16:04
MURA Mural Oncology plc 01 Mar 2024 2 $0 4 Chief Legal Officer and Secretary 04 Mar 2024, 17:18
MURA Mural Oncology plc 14 Dec 2023 2 $0 4 Chief Legal Officer and Secretary 18 Dec 2023, 16:30
MURA Mural Oncology plc 15 Nov 2023 0 $0 3 Chief Legal Officer and Secretary Exhibit 24 - Power of Attorney 15 Nov 2023, 16:01
/report/000117911022000694-keson-brookes-maiken-2022-01-29 Rubius Therapeutics, Inc. 29 Jan 2022 5 -$17,957 4 CLO & Corp. Secretary 01 Feb 2022, 20:19